D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 110 SEK -2.14%
Market Cap: 1.8B SEK

Operating Margin
Devyser Diagnostics AB

-5.3%
Current
-33%
Average
-4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-5.3%
=
Operating Profit
-12.8m
/
Revenue
242.8m

Operating Margin Across Competitors

No Stocks Found

Devyser Diagnostics AB
Glance View

Market Cap
1.9B SEK
Industry
Biotechnology

Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. The company is headquartered in Hagersten, Stockholm. The company went IPO on 2021-12-10. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The firm has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The firm provides its products in more than 45 countries.

DVYSR Intrinsic Value
179.29 SEK
Undervaluation 39%
Intrinsic Value
Price
D
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-5.3%
=
Operating Profit
-12.8m
/
Revenue
242.8m
What is the Operating Margin of Devyser Diagnostics AB?

Based on Devyser Diagnostics AB's most recent financial statements, the company has Operating Margin of -5.3%.

Back to Top